Weiss Multi-Strategy Advisers’s Dimension Therapeutics, Inc DMTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-89,530	Closed	-$537K	–	727
2017 Q3	$537K	Sell	89,530 -260,470	-74%	-$675K	0.02%	421
2017 Q2	$508K	Sell	350,000 -40,403	-10%	-$54.9K	0.02%	437
2017 Q1	$683K	Buy	390,403 +24,489	+7%	+$64.9K	0.03%	430
2016 Q4	$1.59M	Buy	365,914 +125,914	+52%	+$670K	0.08%	233
2016 Q3	$1.92M	Buy	240,000 +4,451	+2%	+$32.2K	0.12%	221
2016 Q2	$1.41M	Buy	235,549 +35,549	+18%	+$271K	0.11%	227
2016 Q1	$1.57M	Buy	200,000 +39,110	+24%	+$308K	0.07%	295
2015 Q4	$1.81M	Buy	+160,890	New	+$2.04M	0.13%	182

Weiss Multi-Strategy Advisers's DMTX Position: Q4 2017 in Review

Weiss Multi-Strategy Advisers sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 89,530 shares — an estimated $537K sold.

Weiss Multi-Strategy Advisers first reported a position in DMTX in Q4 2015 and held it in 8 quarters. The position peaked at $1.92M in Q3 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Weiss Multi-Strategy Advisers reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 89,530 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $537K.
Weiss Multi-Strategy Advisers first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Dimension Therapeutics, Inc position peaked at $1.92M in Q3 2016.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.